Literature DB >> 19516000

Proliferative diabetic retinopathy with lymphocyte-rich epiretinal membrane associated with poor visual prognosis.

Satoru Kase1, Wataru Saito, Shigeaki Ohno, Susumu Ishida.   

Abstract

PURPOSE: The aim of this study was to analyze lymphocyte infiltration using immunohistochemistry in proliferative diabetic retinopathy (PDR) membranes.
METHODS: Sixteen patients, 13 with PDR and 3 without diabetes, underwent pars plana vitrectomy, and the epiretinal membrane was peeled. Formalin-fixed, paraffin-embedded epiretinal membrane tissues were processed for immunohistochemistry with anti-leukocyte common antigen (LCA), CD3, and CD20 antibodies. Lymphocyte density was determined by direct counting at a high magnification under a light microscope, which was compared with the patients' visual prognoses.
RESULTS: The lymphocyte density ranged from 1 to 52 (mean, 9.5) in high-power fields. Of 13 membranes, 5 showed a lymphocyte density of >5 cells, whereas the other 8 membranes showed a cell number of <2. The former type is defined as a lymphocyte-rich epiretinal membrane (LERM). Infiltrated lymphocytes were immunohistochemically positive for CD3, a T-cell marker, but not for CD20, a B-cell marker. All patients with LERM had poor visual prognosis after vitrectomy. In contrast, the visual prognosis in 7 patients with non-LERM improved or remained unchanged. A significant association was observed between high-level lymphocyte infiltration in the epiretinal membrane and poor visual prognosis (P < 0.001). LCA(+) mononuclear cells were not observed in epiretinal membranes in the absence of diabetes.
CONCLUSIONS: These results suggest that the high-level infiltration of T lymphocytes into the PDR membrane is well correlated with poor visual prognosis. Histopathologic observation of the epiretinal membrane in patients with PDR may provide significant prognostic information.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19516000     DOI: 10.1167/iovs.09-3767

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Clinical and histological features of epiretinal membrane after diabetic vitrectomy.

Authors:  Yung-Ray Hsu; Chung-May Yang; Po-Ting Yeh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-15       Impact factor: 3.117

2.  Serum advanced glycation end-products and αB-crystallin in diabetic retinopathy patients.

Authors:  Taku Yamamoto; Satoru Kase; Miyuki Murata; Susumu Ishida
Journal:  Biomed Rep       Date:  2022-02-18

3.  Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy.

Authors:  Ze-Yu Liang; Yi-Peng Wang; Jing Li; Wen-Chao Yang; Yong-Fang Tu; Yue Zhang; Song Chen
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

4.  Leukocyte adhesion molecules in diabetic retinopathy.

Authors:  Kousuke Noda; Shintaro Nakao; Susumu Ishida; Tatsuro Ishibashi
Journal:  J Ophthalmol       Date:  2011-11-02       Impact factor: 1.909

Review 5.  The Vitreomacular Interface in Diabetic Retinopathy.

Authors:  Daniel Agarwal; Rachel Gelman; Claudia Prospero Ponce; William Stevenson; John B Christoforidis
Journal:  J Ophthalmol       Date:  2015-09-03       Impact factor: 1.909

6.  Measurement of serum and vitreous concentrations of anti-type II collagen antibody in diabetic retinopathy.

Authors:  Atsuko Nakaizumi; Masanori Fukumoto; Teruyo Kida; Hiroyuki Suzuki; Seita Morishita; Takaki Satou; Hidehiro Oku; Tsunehiko Ikeda; Kimitoshi Nakamura
Journal:  Clin Ophthalmol       Date:  2015-03-20

7.  Qualitative and Quantitative Analysis of B-Cell-Produced Antibodies in Vitreous Humor of Type 2 Diabetic Patients with Diabetic Retinopathy.

Authors:  Baoyi Liu; Yijun Hu; Qiaowei Wu; Yunkao Zeng; Yu Xiao; Xiaomin Zeng; Ying Fang; Liang Zhang; Tao Li; Honghua Yu
Journal:  J Diabetes Res       Date:  2020-06-30       Impact factor: 4.011

8.  Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy.

Authors:  Mojca Urbančič; Daniel Petrovič; Aleksandra Milutinović Živin; Peter Korošec; Matjaž Fležar; Mojca Globočnik Petrovič
Journal:  Mol Vis       Date:  2020-06-26       Impact factor: 2.367

9.  Gene expression of IGF1, IGF1R, and IGFBP3 in epiretinal membranes of patients with proliferative diabetic retinopathy: preliminary study.

Authors:  Dorota Romaniuk; Malgorzata W Kimsa; Barbara Strzalka-Mrozik; Magdalena C Kimsa; Adam Kabiesz; Wanda Romaniuk; Urszula Mazurek
Journal:  Mediators Inflamm       Date:  2013-11-28       Impact factor: 4.711

10.  A flow cytometric analysis of vitreous inflammatory cells in patients with proliferative diabetic retinopathy.

Authors:  Mojca Urbančič; Veronika Kloboves Prevodnik; Daniel Petrovič; Mojca Globočnik Petrovič
Journal:  Biomed Res Int       Date:  2013-10-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.